Skip to main content

Primary macronodular adrenal hyperplasia (PMAH)

Primary macronodular adrenal hyperplasia (PMAH)



Overview

Primary macronodular adrenal hyperplasia (PMAH) is a rare disorder causing bilateral enlargement of the adrenal glands with multiple distinct nodules, leading to the overproduction of cortisol. It usually manifests in a person's 40s or 50s and results in Cushing syndrome

Symptoms

Because PMAH causes excess cortisol production that is independent of the pituitary gland, patients primarily show symptoms associated with Cushing's syndrome:

Physical Changes: "Moon face" (rounded face), a "buffalo hump" (fat deposit between the shoulders), and increased abdominal fat.

Skin Issues: Thin, fragile skin that bruises easily, slow-healing cuts, and red or purple stretch marks (striae).

Bone and Muscle: Muscle wasting (especially in the upper thighs and arms) and bone density loss (osteoporosis).

Excess cortisol heavily impacts metabolism and cardiovascular health:

Hypertension: High blood pressure is a very common complication.

Blood Sugar Imbalances: Increased risk of insulin resistance, pre-diabetes, or new-onset diabetes mellitus.

Fatigue: Ongoing lethargy, weakness, and generalized exhaustion.

Causes

ARMC5 Gene Mutations: This tumor-suppressor gene is the most common known genetic cause, accounting for over 80% of familial PMAH cases and about 30% of sporadic cases. Inherited in an autosomal dominant pattern, it requires a secondary somatic mutation in the adrenal cells to manifest.

GNAS Gene Mutations: These occur sporadically (not inherited) early in embryonic development. They result in an overactive G-protein, leading to an excess of cyclic AMP (cAMP) and uncontrolled cell proliferation.

Other Genetic Defects: Rarer forms and variants are associated with mutations in the KDM1A gene (specifically in food-dependent Cushing's syndrome) as well as the PRKAR1A and PDE11A genes.

Diagnosis

1. Biochemical Evaluation 

The cornerstone of diagnosing PMAH is establishing the presence of mild or overt Cushing's syndrome that is independent of pituitary control.

Low-dose dexamethasone suppression test: Used as the primary screening tool to evaluate for autonomous cortisol secretion.

Plasma ACTH levels: Typically suppressed or low, confirming the condition is ACTH-independent.

Additional Tests: 24-hour urinary free cortisol (UFC) and midnight salivary cortisol levels are often measured to confirm hypercortisolism.2. Radiological Imaging is required to identify the distinct morphological enlargement of the glands.

CT/MRI Scans: Reveals bilateral (and occasionally unilateral in early stages) adrenal enlargement with multiple distinct nodules measuring \(>1\text{ cm}\).

Evaluation: Nodules should be characterized separately on a lesion-by-lesion basis to rule out the co-occurrence of other adrenal entities (e.g., myelolipomas, adenomas, or carcinomas).

3. Genetic and Molecular Testing

Because a significant proportion of PMAH cases are familial, genetic testing is often recommended to understand the etiology and screen for associated risks.ARMC5 Mutations: Germline mutations in the ARMC5 gene are the most frequent genetic defect, accounting for up to 50% of PMAH cases.KDM1A Mutations: Mutations in KDM1A are also recognized as drivers in the development of PMAH.

Treatment

Primary macronodular adrenal hyperplasia (PMAH) treatment primarily involves surgical removal of the adrenal glands to stop excess cortisol production. The choice depends on disease severity, with Unilateral Adrenalectomy increasingly preferred for mild cases to prevent lifetime hormone dependence, while Bilateral Adrenalectomy is used for severe Cushing's syndrome. The appropriate management plan is determined by the severity of the hypercortisolism (excess cortisol) and the patient's overall health. The primary options include

1. Surgical Management Surgery is the most definitive and widely recommended treatment for PMAH.

Unilateral Adrenalectomy: Often considered the first-line treatment for patients with mild to moderate Cushing's syndrome or asymptomatic autonomous cortisol secretion. It removes the most enlarged adrenal gland to decrease cortisol levels. The benefit is that the remaining gland may recover, allowing the patient to avoid lifetime hormone replacement therapy.

Bilateral Adrenalectomy: The traditional "gold standard" for patients with severe, overt Cushing's syndrome or life-threatening comorbidities. While it guarantees the normalization of cortisol levels, it requires the patient to take lifelong glucocorticoid and mineralocorticoid replacement therapy and puts them at risk of potential adrenal crises.

Adrenal-Sparing Surgery: In some centers, total removal of the larger gland combined with subtotal removal of the smaller gland is performed to prevent permanent adrenal insufficiency, though the risk of hormone recurrence remains.

2. Medical Management Medications are generally used when surgery is not an option, or as a bridge to stabilize a patient with severe hypercortisolism prior to surgery.

Steroidogenesis Inhibitors: Drugs like Ketoconazole or Metyrapone act directly to inhibit the enzymes that synthesize cortisol, alleviating symptoms of excess hormone production.

Receptor Antagonists: In specific cases of PMAH, cortisol secretion is driven by aberrant hormone receptors (e.g., G-protein coupled receptors). In these cases, medications such as beta-blockers or somatostatin analogs may be used to block the receptors that stimulate the adrenal glands. For detailed clinical perspectives on the surgical and medical approaches, you can review this article on Primary Macronodular Adrenal Hyperplasia (PMAH) via clinic. Alternatively, for an in-depth clinical study, consult the Diagnosis and Management of Primary Bilateral Macronodular Adrenal Hyperplasia via Endocrine-Related Cancer.

Type of Doctor Department : An Endocrinologist

Comments

Post a Comment

Popular posts from this blog

Charge Syndrome

Overview CHARGE syndrome is a recognizable genetic syndrome with known pattern of features. It is an extremely complex syndrome, involving extensive medical and physical difficulties that differ from child to child. CHARGE syndrome is correlated with genetic mutation to CHD7 and the prevalence of CHARGE syndrome is 1:10,000-1:15,000 live births. Babies with CHARGE syndrome are often born with life-threatening birth defects. They spend many months in the hospital and undergo many surgeries and other treatments. Swallowing and breathing problems make life difficult even when they come home. Most have hearing two little girls sitting on a carpet, one girl has a trach and is biting her finger.loss, vision loss, and balance problems that delay their development and communication. Despite these seemingly insurmountable obstacles, children with CHARGE syndrome often far surpass their medical, physical, educational, and social expectations. One of the hidden features of CHARGE syndrome is the ...
7 comments
Read more

Dehydration Due to Diarrheal Diseases

Overview Dehydration occurs when you use or lose more fluid than you take in, and your body doesn't have enough water and other fluids to carry out its normal functions. If you don't replace lost fluids, you will get dehydrated. Anyone may become dehydrated, but the condition is especially dangerous for young children and older adults. The most common cause of dehydration in young children is severe diarrhea and vomiting. Older adults naturally have a lower volume of water in their bodies, and may have conditions or take medications that increase the risk of dehydration. This means that even minor illnesses, such as infections affecting the lungs or bladder, can result in dehydration in older adults. Dehydration also can occur in any age group if you don't drink enough water during hot weather — especially if you are exercising vigorously. You can usually reverse mild to moderate dehydration by drinking more fluids, but severe dehydration needs immediate medical treatment. ...
Post a Comment
Read more

Ataxia with Vitamin E Deficiency

Synonyms of Ataxia with Vitamin E Deficiency AVED Familial Isolated Vitamin E Deficiency Isolated Vitamin E Deficiency General Discussion Ataxia with vitamin E deficiency (AVED) is a rare inherited neurodegenerative disorder characterized by impaired ability to coordinate voluntary movements (ataxia) and disease of the peripheral nervous system (peripheral neuropathy). AVED is a progressive disorder that can affect many different systems of the body (multisystem disorder). Specific symptoms vary from case to case. In addition to neurological symptoms, affected individuals may experience eye abnormalities, disorders affecting the heart muscles (cardiomyopathy), and abnormal curvature of the spine (scoliosis). AVED is extremely similar to a more common disorder known as Friedreich’s ataxia. AVED is inherited as an autosomal recessive trait. Vitamin E deficiency often occurs secondary to disorders that impair the absorption of vitamin E from fat including liver disorders, disorders of fat...
Post a Comment
Read more